Your browser doesn't support javascript.
Knowledge mobilization activities to support decision-making by youth, parents, and adults using a systematic and living map of evidence and recommendations on COVID-19: protocol for three randomized controlled trials and qualitative user-experience studies.
Charide, Rana; Stallwood, Lisa; Munan, Matthew; Sayfi, Shahab; Hartling, Lisa; Butcher, Nancy J; Offringa, Martin; Elliott, Sarah; Richards, Dawn P; Mathew, Joseph L; Akl, Elie A; Kredo, Tamara; Mbuagbaw, Lawrence; Motillal, Ashley; Baba, Ami; Prebeg, Matthew; Relihan, Jacqueline; Scott, Shannon D; Suvada, Jozef; Falavigna, Maicon; Klugar, Miloslav; Lotfi, Tamara; Stevens, Adrienne; Pottie, Kevin; Schünemann, Holger J.
  • Charide R; Michael G. DeGroote Cochrane Canada and McMaster GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W, Hamilton, Ontario, L8S 4K1, Canada.
  • Stallwood L; Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Munan M; Alberta Research Centre for Health Evidence, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Sayfi S; Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
  • Hartling L; Alberta Research Centre for Health Evidence, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Butcher NJ; Cochrane Child Health, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • Offringa M; Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Elliott S; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Richards DP; Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Mathew JL; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Akl EA; Division of Neonatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Kredo T; Alberta Research Centre for Health Evidence, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Mbuagbaw L; Cochrane Child Health, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • Motillal A; Five02 Labs Inc, Toronto, Ontario, Canada.
  • Baba A; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada.
  • Prebeg M; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Relihan J; Michael G. DeGroote Cochrane Canada and McMaster GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W, Hamilton, Ontario, L8S 4K1, Canada.
  • Scott SD; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
  • Suvada J; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
  • Falavigna M; Division of Clinical Pharmacology, Department of Medicine and Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
  • Klugar M; Michael G. DeGroote Cochrane Canada and McMaster GRADE Centres, Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main St. W, Hamilton, Ontario, L8S 4K1, Canada.
  • Lotfi T; Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada.
  • Stevens A; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Pottie K; Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, Hamilton, Ontario, Canada.
  • Schünemann HJ; Centre for Development of Best Practices in Health (CDBPH), Yaoundé Central Hospital, Yaoundé, Cameroon.
Trials ; 24(1): 27, 2023 Jan 14.
Article in English | MEDLINE | ID: covidwho-2196416
ABSTRACT

INTRODUCTION:

The COVID-19 pandemic underlined that guidelines and recommendations must be made more accessible and more understandable to the general public to improve health outcomes. The objective of this study is to evaluate, quantify, and compare the public's understanding, usability, satisfaction, intention to implement, and preference for different ways of presenting COVID-19 health recommendations derived from the COVID-19 Living Map of Recommendations and Gateway to Contextualization (RecMap). METHODS AND

ANALYSIS:

This is a protocol for a multi-method study. Through an online survey, we will conduct pragmatic allocation-concealed, blinded superiority randomized controlled trials (RCTs) in three populations to test alternative formats of presenting health

recommendations:

adults, parents, and youth, with at least 240 participants in each population. Prior to initiating the RCT, our interventions will have been refined with relevant stakeholder input. The intervention arm will receive a plain language recommendation (PLR) format while the control arm will receive the corresponding original recommendation format as originally published by the guideline organizations (standard language version). Our primary outcome is understanding, and our secondary outcomes are accessibility and usability, satisfaction, intended behavior, and preference for the recommendation formats. Each population's results will be analyzed separately. However, we are planning a meta-analysis of the results across populations. At the end of each survey, participants will be invited to participate in an optional one-on-one, virtual semi-structured interview to explore their user experience. All interviews will be transcribed and analyzed using the principles of thematic analysis and a hybrid inductive and deductive approach. ETHICS AND DISSEMINATION Through Clinical Trials Ontario, the Hamilton Integrated Research Ethics Board has reviewed and approved this protocol (Project ID 3856). The University of Alberta has approved the parent portion of the trial (Project ID00114894). Findings from this study will be disseminated through open-access publications in peer-reviewed journals and using social media. TRIAL REGISTRATION Clinicaltrials.gov NCT05358990 . Registered on May 3, 2022.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Adolescent / Adult / Humans Country/Region as subject: North America Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2023 Document Type: Article Affiliation country: S13063-023-07067-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Adolescent / Adult / Humans Country/Region as subject: North America Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2023 Document Type: Article Affiliation country: S13063-023-07067-9